Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 4, 2025Therapeutic Advances in HematologyOpen Access

Calcineurin inhibitor and eltrombopag combination for acquired aplastic anemia: results from a large national database

View Full Paper
Ask AI
Bookmark
Share

Authors

RWRong WangNPNikolai A. Podoltsev

Discussion

Loading...

Member takes

Overview

Retrospective cohort study shows reduced transfusion burden in adults with acquired aplastic anemia, suggesting CNI and eltrombopag efficacy.

Key Points

  • Double therapy with calcineurin inhibitor and eltrombopag reduced transfusion needs in patients with acquired aplastic anemia.
  • Among 153 patients, 66% achieved transfusion independence after receiving combined therapy for 6 months.
  • Retrospective cohort study reviewed records from the Blue Cross Blue Shield Axis Database on patient outcomes after treatment.
  • Findings highlight the practicality of double therapy for those ineligible for triple therapy and indicate potential for broader application.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/6930dc6bea1aef094cca1ed2https://doi.org/10.1177/20406207251394775
View Full Paper
Ask AI
Bookmark
Share